Strikingly, transplantation of Egr-wild-type immune cells could rescue the progression of scrib, Rasv12 tumours, as well as JNK activation, providing the final demonstration that Drosophila TNF shares protumour effects with its mammalian counterpart [36] (Figure 1). The gene discussed is SCRIB; the disease is neoplasm.